Quick Overview: Pamela L. Kunz, MD, Yale University School of Medicine, New Haven, CT, reports on the final analysis of efficacy and evaluation ... Elizabeth Plimack, MD, MS, of the Fox Chase Cancer Center, Philadelphia, PA talks about The Imugene managing director Dr Leslie Chong talked with Proactive about the company's latest advancements in its allogeneic ...
Ecog Acrin E2211 Mgmt Predictive - Detailed Overview & Context
Pamela L. Kunz, MD, Yale University School of Medicine, New Haven, CT, reports on the final analysis of efficacy and evaluation ... Elizabeth Plimack, MD, MS, of the Fox Chase Cancer Center, Philadelphia, PA talks about The Imugene managing director Dr Leslie Chong talked with Proactive about the company's latest advancements in its allogeneic ... Prof Hans Gelderblom speaks to ecancer about the phase III MANEUVER trial. Tenosynovial giant cell tumour (TGCT) is a rare, ... Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. Standard treatment now includes a DNA ... 0:00 2:56 Introductions 4:55 Patients: Share Your Experiences with the FDA 5:42 The Basics: What is avacopan (Tavneos)?
NETRF.org is a leading funder of neuroendocrine tumor research in the U.S. and abroad. As a nonprofit foundation, NETRF is ... In this NETmed Session, Jason Starr, DO, interviews Pamela Kunz, MD on her recent European Neuroendocrine Tumor Society ... ABOUT THIS EPISODE What is the difference between Pancreatic Neuroendocrine Tumor (PNET) and Pancreatic Cancer? Asst. Prof Bishal Gyawali talks to ecancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting about his ... Dr. Andrew Lassman discusses his research at the ASCO 2016 meeting in Chicago. Retatrutide is one of the most talked-about drugs in longevity and metabolic health, but what does switching to it actually mean for ...
Pamela L. Kunz, MD, assistant professor, Division of Oncology, Stanford University School of Medicine, discusses the sequencing ... This session was recorded during the Cholangiocarcinoma Foundation Annual Conference Science Track on May 1, 2026. Alicia Pliego Mendieta from the Laboratory for Systems Pathology and Functional Tumor Pathology at the University of Zurich, ... Mark Litzow, MD, Mayo Clinic, Rochester, MN, shares the results of Incorporating Genomic Testing, Advanced Imaging, and Artificial Intelligence for Prostate Cancer into Your Practice (2026) CME ...
